Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Soapbox Science is coming to Oxford for the third year running thanks to a collaboration between the University of Oxford and Oxford Brookes University.

Scientists at 2017 'Soapbox Science' event

Soapbox Science is a novel public outreach platform for promoting women scientists and the science they do. Their events transform public areas into an arena for public learning and scientific debate; they follow the format of London Hyde Park’s Speaker’s Corner, which is historically an arena for public debate. The aim of Soapbox Science is to give everyone the opportunity to enjoy, learn from, heckle, question, probe, interact with and be inspired by leading scientists.

Two previous Soapbox Science events in Oxford have transformed Cornmarket Street and Magdalen College School into an arena for science communication and public interaction, and this Saturday 28 July the next event will be held at Bonn Square in Oxford from 1pm – 4pm.

A number of scientists from across the Medical Sciences Division will be taking part in this year’s Soapbox Science, exploring the following topics:

Other scientists will explore topics including robot doctors and venomous primates – find out more and come along.

Soapbox Science Oxford is a collaboration between the University of Oxford and Oxford Brookes University. It is organised by Carlyn Samuel (Interdisciplinary centre of of Conservation Science at the University of Oxford) Ravinder Kander (department of Biological and Medicinal Sciences, Oxford Brookes University) and Dong Liu (Department of Materials, University of Oxford).

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.